StockData
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc. (LRMR) stock

LRMRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 6/30
$2.70−0.03 (-1.10%)

Close on Nov 12, 2026Market cap $280.48MP/E –Yield –

Larimar Therapeutics statistics

56 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 18, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$280.48M
$280.48M
Enterprise Value
$124.18M
$148.62M
PB Ratio
2.20
2.05
P/TBV Ratio
2.20
2.29

Share statisticsIndustry

Shares Change (QoQ)
0.00%
0.48%
Float
35M
49M
Shares Held by Insiders
66.3%
12.1%
Shares Held by Institutions
91.9%
56.4%

Short sellingIndustry

Short Interest
11M
–
Short Interest Change
-28.1%
-0.76%
Short % of Float
30.1%
9.06%
Short % of Shares Outstanding
10.1%
6.30%
Days to Cover
8.25
5.13

Stock price statisticsIndustry

52-Week High
$6.42
–
52-Week Low
$1.92
–
20-Day Moving Average
$2.45
–
50-Day Moving Average
$2.95
–
200-Day Moving Average
$3.77
–
Average True Range (14)
$0.24
–
Price Change (1 Week)
16.4%
1.51%
Price Change (1 Month)
29.2%
-2.37%
Price Change (3 Months)
-38.1%
-21.1%
Price Change (6 Months)
-30.6%
-22.8%
Price Change (YTD)
-29.1%
-22.6%
Price Change (1 Year)
-25.6%
-21.0%
Price Change (3 Years)
13.0%
-24.8%
Price Change (5 Years)
-76.3%
-76.9%
Price Change (10 Years)
-93.6%
-63.2%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
1M
–
Relative Volume
0.88
0.80
Relative Strength Index (14)
52.1
44.7
Volatility (1 Year)
101.1%
80.2%
Beta (5 Years)
1.33
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-139.6%
-51.3%
Return on Assets (ROA)
-109.5%
-40.7%
Return on Capital Employed (ROCE)
-136.5%
-38.1%

Financial positionIndustry

Current Ratio
4.70
3.31
Quick Ratio
4.57
2.41

EfficiencyIndustry

Profits Per Employee
-$2.43M
-$683.67K
Employee Count
71
75
WACC
11.5%
10.0%

Income statement (TTM)Industry

Operating Income
-$178.99M
-$20.99M
Net Income
-$172.61M
-$21.61M
EBITDA
-$178.99M
-$16.85M

Balance sheetIndustry

Net Cash (Debt)
$156.30M
$16.98M
Net Cash Per Share
$1.50
$0.72
Equity (Book Value)
$127.38M
$52.68M
Book Value Per Share
$1.23
$1.50
Tangible Book Value
$127.38M
$26.74M
Working Capital
$126.51M
$78.52M

Dividends and yieldsIndustry

Earnings Yield
-61.5%
-21.0%

Scores and fair valueIndustry

Altman Z-Score
-2.43
0.26

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodLRMRS&P 500DifferenceLRMR per yearS&P 500 per year
1 month+6.7%-2.7%+9.4 pts
3 months-38.2%-1.7%−36.5 pts
Year to date-29.1%+11.9%−41.0 pts
1 year-19.9%+12.0%−31.9 pts
3 years+10.2%+78.2%−68.0 pts+3.3%+21.2%
5 years-76.3%+73.2%−149.6 pts-25.0%+11.6%
10 years-93.6%+309.6%−403.2 pts-24.0%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

11M LRMR shares were sold short on Oct 30, 2026, down 28.1% from the previous report, or 30.14% of the shares available to trade. At recent volumes it would take 8.3 days to buy them back. Over the last 20 sessions, 52.1% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202610,538,346-28.1%1,277,7568.3
Oct 15, 202614,662,909-4.6%1,637,6298.9
Sep 30, 202615,369,771+10.6%1,767,3378.7
Sep 15, 202613,894,306+1.3%932,91514.9
Aug 31, 202613,721,861+2.1%895,15115.3
Aug 14, 202613,443,456+10.3%1,196,76911.2
Jul 31, 202612,190,367+7.8%1,299,5729.4
Jul 15, 202611,303,953-7.3%2,310,4044.9
Jun 30, 202612,193,251+15.7%3,837,6403.2
Jun 15, 202610,535,603+30.9%2,080,7235.1
May 29, 20268,046,494-8.0%1,523,7535.3
May 15, 20268,744,601+5.2%2,025,6774.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?